Keros Therapeutics

Keros Therapeutics, Inc. was founded in 2015 and is headquartered in Lexington, Massachusetts, USA. Keros is a biopharmaceutical company focused on hematological and musculoskeletal disorders, dedicated to discovering and developing differentiated therapies that modulate the TGF-β (Transforming Growth Factor-β) signaling pathway to treat diseases with significant unmet medical needs.Keros is recognized as a leader in the discovery, development, and commercialization of novel therapies, leveraging its deep understanding of the function of TGF-β family proteins, which are key regulators of red blood cell and platelet production as well as the growth, repair, and maintenance of muscles and bones.